2017 Sec 1 Green Book

Z. Farhood et al. / International Journal of Pediatric Otorhinolaryngology 89 (2016) 149 e 153

[25] C. Gregorowski, C. Lochner, L. Martin, et al., Neuropsychological manifesta- tions in children with Sydenham's chorea after adjunct intravenous immu- noglobulin and standard treatment, Metab. Brain Dis. 31 (1) (2016) 205 e 212 . [26] G. Jonasson, S.R. Wilkinson, Prednisolone-induced obsessive-compulsive behavior in a child, Tidsskr. Nor. Laegeforen. 113 (25) (1993) 3162 e 3163 . [27] A.H. Zohar, The epidemiology of obsessive-compulsive disorder in children and adolescents, Child. Adolesc. Psychiatr. Clin. N. Am. 8 (3) (1999) 445 e 460 . [28] T.K. Murphy, E.A. Storch, M.S. Strawser, Selective serotonin reuptake

inhibitor-induced behavioral activation in the PANDAS subtype, Prim. Psy- chiatry 13 (8) (2006) 87 e 89 . [29] J.S. March, Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS): implications for clinical practice, Arch. Pediatr. Adolesc. Med. 158 (9) (2004) 927 e 929 . [30] ClinicalTrials.gov. Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS (ATIVPANDAS). https://clinicaltrials.gov/ct2/show/ NCT01769027?term ¼ PANDAS & rank ¼ 4 . accessed 24.03.16.

61